Today: 19 June 2026
Browse Category

Earnings Reports 13 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
Lockheed Martin stock nears a fresh high after Jefferies target hike as earnings loom

Lockheed Martin stock nears a fresh high after Jefferies target hike as earnings loom

Lockheed Martin shares rose about 1% Tuesday, peaking at $564. Jefferies raised its price target to $540 but kept a Hold rating, citing possible weakness in 2026 guidance. Lockheed delivered its 350th MH-60R helicopter to the U.S. Navy and hosted Secretary of War Pete Hegseth at its F-35 plant. Investors await fourth-quarter results on Jan. 29 for details on 2026 margins and production.
Roblox stock jumps as BMO flags a breakout game and Feb. 5 earnings loom (RBLX)

Roblox stock jumps as BMO flags a breakout game and Feb. 5 earnings loom (RBLX)

Roblox shares rose 8% to $83.09 in midday New York trading Tuesday, after touching $83.98 and trading as low as $76.05. The company will report fourth-quarter and full-year 2025 results after the bell on Feb. 5. BMO reiterated an Outperform rating, citing strong early performance of a new game. New York’s governor is pushing for stricter online gaming rules affecting Roblox, The Verge reported.
Why Goldman Sachs stock is down today: Apple Card handoff and CPI sharpen focus on Jan. 15 earnings

Why Goldman Sachs stock is down today: Apple Card handoff and CPI sharpen focus on Jan. 15 earnings

Goldman Sachs shares fell 0.8% to $942.01 in midday New York trading Tuesday as big banks began reporting earnings. JPMorgan booked a $2.2 billion provision tied to taking over the Apple Card from Goldman. U.S. core inflation rose 0.2% in December, steadying bets on Federal Reserve rate cuts. Treasury yields slipped after the inflation data.
Scorpio Tankers stock jumps nearly 9% on net-cash update as investors eye a February catalyst

Scorpio Tankers stock jumps nearly 9% on net-cash update as investors eye a February catalyst

Scorpio Tankers shares surged nearly 9% to $59.85 by midday Tuesday after the company reported a net cash position of $164.7 million, outstripping its debt. A U.S. filing showed Scorpio agreed to sell the LR2 tanker STI Kingsway for $57.5 million, with closing expected in early 2026. Investors are watching the timing of vessel sales and related cash flows. Peers Frontline and International Seaways rose about 3%.
Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

Option Care Health (OPCH) stock jumps nearly 10% on early Q4 results, 2026 outlook and a bigger buyback

Option Care Health shares rose nearly 10% to $35.16 Tuesday after the company released preliminary Q4 results and doubled its share buyback authorization to $1.0 billion. The company projects Q4 net revenue of $1.46–$1.47 billion and adjusted EPS of $0.46–$0.49. A Citizens analyst raised the price target to $38, citing easing Stelara-related risk after 2026.
Johnson & Johnson stock jumps as Delaware court pares Auris damages hit, earnings next week

Johnson & Johnson stock jumps as Delaware court pares Auris damages hit, earnings next week

Johnson & Johnson shares rose 1.6% to $212.98 Tuesday, outperforming a dip in healthcare stocks. Delaware’s Supreme Court ordered a recalculation of part of a $1 billion damages award tied to the Auris acquisition, which could reduce the payout by hundreds of millions. Legal developments and upcoming drug trial data are in focus ahead of the company’s Jan. 21 earnings call.
Bank of America stock slips as Trump credit-card cap clouds BAC earnings

Bank of America stock slips as Trump credit-card cap clouds BAC earnings

Bank of America shares fell 0.9% to $54.72 Tuesday after President Trump proposed a 10% cap on credit-card interest rates. The move follows a 1.6% drop Monday and comes as U.S. inflation data met expectations, leaving the Fed’s rate outlook unchanged. Bank trade groups warned the cap could force lenders to close or restrict most credit-card accounts for borrowers with scores under 740. Investors await Bank of America’s quarterly results.
Broadcom stock nudges higher after CPI as traders eye Fed and March earnings

Broadcom stock nudges higher after CPI as traders eye Fed and March earnings

Broadcom shares rose 0.6% to $354.15 in early New York trading Tuesday, outperforming other chip stocks during a volatile session. U.S. consumer prices increased 0.3% in December, keeping inflation and Fed rate expectations in focus ahead of the Jan. 27-28 policy meeting. Investors await Broadcom’s quarterly results set for March 4, with attention on AI chip margins.
Microsoft stock dips as new data-center “power bill” pledge lands ahead of earnings

Microsoft stock dips as new data-center “power bill” pledge lands ahead of earnings

Microsoft shares fell 0.4% to $477.18 Tuesday after the company announced new measures to limit electricity and water use at its U.S. data centers. The plan comes amid rising local opposition to AI infrastructure costs. Investors are watching for Microsoft’s Jan. 28 earnings to gauge Azure and AI demand. Barclays cut its price target but kept an “Overweight” rating.
Dow and S&P 500 futures rise after CPI cools on core as JPMorgan kicks off earnings

Dow and S&P 500 futures rise after CPI cools on core as JPMorgan kicks off earnings

U.S. stock index futures rose after December core CPI increased 0.2%, below forecasts. JPMorgan beat profit estimates but recorded a $2.2 billion charge tied to its Apple Card deal. Bank of New York Mellon shares slipped despite a higher profitability target. Delta Air Lines tumbled on a muted earnings outlook, pulling other airlines lower.
Intel stock slips premarket despite KeyBanc upgrade as traders eye Jan. 22 earnings

Intel stock slips premarket despite KeyBanc upgrade as traders eye Jan. 22 earnings

Intel shares fell 3.3% to $44.06 in premarket trading Tuesday despite a KeyBanc upgrade to Overweight and a $60 target, citing strong server chip demand and improved 18A yields. KeyBanc said Intel is largely sold out of server CPUs for 2026 and may raise prices 10–15%. Investors await Intel’s Jan. 22 earnings for updates on pricing and foundry progress. AMD rose 2.2% after a similar upgrade.
Nvidia stock in premarket: H200 China payment clarification, Lilly AI lab and TSMC earnings in focus

Nvidia stock in premarket: H200 China payment clarification, Lilly AI lab and TSMC earnings in focus

Nvidia shares were flat in premarket trading after the company said customers in China won’t need to pay upfront for its H200 AI chips. Nvidia and Eli Lilly announced a $1 billion, five-year partnership to build an AI drug research lab in the Bay Area. Chip stocks rose, with Taiwan Semiconductor up nearly 2.5% ahead of its Jan. 15 earnings report.
Chewy stock jumps on Viking Global stake disclosure — what to watch before CHWY’s next earnings

Chewy stock jumps on Viking Global stake disclosure — what to watch before CHWY’s next earnings

Chewy shares traded at $33.92 premarket Tuesday, little changed after a 5.7% surge Monday. A Schedule 13G filing showed Viking Global Investors owned 5.7% of Chewy’s Class A stock as of December 18, more than doubling its stake since September. Investors are watching for further ownership disclosures and the next earnings report, expected in late March. Chewy last posted quarterly sales of $3.12 billion and net income of $59.2 million.
1 146 147 148 149 150 257

Stock Market Today

  • New Zealand Shares Rise on US-Iran Agreement; SkyCity Entertainment Signs Heads of Agreement with South Australia
    June 19, 2026, 2:15 AM EDT. New Zealand shares climbed 0.99% on Friday, boosted by the US-Iran 14-point deal reopening the Strait of Hormuz. The S&P/NZX 50 Index closed at 13,495.63. Domestic data showed a May goods trade surplus of NZ$800 million, down from NZ$1.6 billion in April. March-quarter GDP data indicated monetary easing benefits through business investment and trade. In corporate news, SkyCity Entertainment Group entered a nonbinding heads of agreement with the South Australian Gambling Commissioner involving a AU$21 million total fine. Meanwhile, Rua Gold confirmed potential to expand its gold-antimony resource at Auld Creek, South Island.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop